8AG1
Crystal structure of a novel OX40 antibody
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U |
Synchrotron site | SSRF |
Beamline | BL17U |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2017-10-01 |
Detector | DECTRIS PILATUS 12M |
Wavelength(s) | 0.97853 |
Spacegroup name | P 62 2 2 |
Unit cell lengths | 162.356, 162.356, 232.145 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 77.502 - 3.303 |
Rwork | 0.194 |
R-free | 0.26810 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2EHY |
RMSD bond length | 0.002 |
RMSD bond angle | 0.593 |
Data reduction software | iMOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | REFMAC (8.0.002) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 77.502 | 3.500 |
High resolution limit [Å] | 3.300 | 3.300 |
Rmerge | 0.168 | 1.945 |
Number of reflections | 27927 | 4370 |
<I/σ(I)> | 9.1 | 1.5 |
Completeness [%] | 99.7 | |
Redundancy | 10.6 | |
CC(1/2) | 0.994 | 0.670 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | EVAPORATION | 5 | 293 | 0.1m CITRATE, PH5.6, 2% TACSIMATE, 16% PEG3350 |